Skip to main content

Advertisement

SpringerLink
Log in

Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

To assess the effects of the combination of pelvic floor rehabilitation and intravaginal estriol administration on stress urinary incontinence (SUI), urogenital atrophy and recurrent urinary tract infections in postmenopausal women.

Methods

Two-hundred-six postmenopausal women with urogenital aging symptoms were enrolled in this prospective randomized controlled study. Patients were randomly divided into two groups and each group consisted of 103 women. Subjects in the treatment group received intravaginal estriol ovules, such as 1 ovule (1 mg) once daily for 2 weeks and then 2 ovules once weekly for a total of 6 months as maintenance therapy plus pelvic floor rehabilitation. Subjects in the control group received only intravaginal estriol in a similar regimen. We evaluated urogenital symptomatology, urine cultures, colposcopic findings, urethral cytologic findings, urethral pressure profiles and urethrocystometry before, as well as after 6 months of treatment.

Results

After therapy, the symptoms and signs of urogenital atrophy significantly improved in both groups. 61/83 (73.49%) of the treated patients, and only 10/103 (9.71%) of the control patients referred a subjective improvement of their incontinence. In the patients treated by combination therapy with estriol plus pelvic floor rehabilitation, we observed significant improvements of colposcopic findings, and there were statistically significant increases in mean maximum urethral pressure (MUP), in mean urethral closure pressure (MUCP), as well as in the abdominal pressure transmission ratio to the proximal urethra (PTR).

Conclusions

Our results showed that combination therapy with estriol plus pelvic floor rehabilitation was effective and should be considered as a first-line treatment for symptoms of urogenital aging in postmenopausal women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Greendale GA, Judd HL (1993) The menopause: health implications and clinical management. J Am Geriatr Soc 41:426–436

    PubMed  CAS  Google Scholar 

  2. Cardozo L, Bachmann G, McClish D, Fonda D, Birgenson L (1998) Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the hormones and urogenital therapy committee. Obstet Gynecol 92:722–727

    Article  PubMed  CAS  Google Scholar 

  3. Barlow DH, Samsioe G, van Geelen JH (1997) A study of European women’s experience of the problems of urogenital ageing and its management. Maturitas 27:239–247

    Article  PubMed  CAS  Google Scholar 

  4. Samsioe G (1998) Urogenital aging. A hidden problem. Am J Obstet Gynecol 178:S245–S249

    Article  PubMed  CAS  Google Scholar 

  5. Iosif CS, Batra S, Ek A, Astedt B (1981) Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol 141:817–820

    PubMed  CAS  Google Scholar 

  6. Smith P (1993) Estrogens and the urogenital tract. Acta Obstet Gynecol Scand 157(suppl):1–25

    CAS  Google Scholar 

  7. Samsioe G, Jansson I, Mellstrom D, Svanborg A (1985) Occurrence, nature and treatment of urinary incontinence in a 70-year-old female population. Maturitas 7:335–342

    Article  PubMed  CAS  Google Scholar 

  8. Nilsson K, Heimer G (1992) Low-dose oestradiol in the treatment of urogenital oestrogen deficiency: a pharmacokinetic and pharmacodynamic study. Maturitas 15:121–127

    Article  PubMed  CAS  Google Scholar 

  9. Smith P, Heimer G, Lindskog M, Ulmsten U (1993) Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy. Maturitas 16:145–154

    Article  PubMed  CAS  Google Scholar 

  10. Fantl JA, Cardozo L, McClish DK (1994) Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the hormones and urogenital therapy committee. Obstet Gynecol 83:12–18

    PubMed  CAS  Google Scholar 

  11. Dessole S, Rubattu G, Ambrosini G, Gallo O, Capobianco G, Cherchi PL, Marci R, Cosmi E (2004) Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Menopause 11:49–56

    Article  PubMed  Google Scholar 

  12. Esposito G (1991) Estriol: a weak estrogen or a different hormone? Gynecol Endocrinol 5:131–153

    Article  PubMed  CAS  Google Scholar 

  13. Heimer GM, Englund DE (1992) Effects of vaginally-administered oestriol on post-menopausal urogenital disorders: a cytohormonal study. Maturitas 14:171–179

    Article  PubMed  CAS  Google Scholar 

  14. Iosif CS (1992) Effects of protracted administration of estriol on the lower genito urinary tract in postmenopausal women. Arch Gynecol Obstet 251:115–120

    Article  PubMed  CAS  Google Scholar 

  15. Foidart JM, Vervliet J, Buytaert P (1991) Efficacy of sustained-release vaginal oestriol in alleviating urogenital and systemic climacteric complaints. Maturitas 13:99–107

    Article  PubMed  CAS  Google Scholar 

  16. Van der Linden MC, Gerretsen G, Brandhorst MS, Ooms EC, Kremer CM, Doesburg WH (1993) The effect of estriol on the cytology of urethra and vagina in postmenopausal women with genito-urinary symptoms. Eur J Obstet Gynecol Reprod Biol 51:29–33

    Article  PubMed  Google Scholar 

  17. Henriksson L, Stjernquist M, Boquist L, Alander U, Selinus I (1994) A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol 171:624–632

    PubMed  CAS  Google Scholar 

  18. Bottiglione F, Volpe A, Esposito G, Aloysio DD (1995) Transvaginal estriol administration in postmenopausal women: a double blind comparative study of two different doses. Maturitas 22:227–232

    Article  PubMed  CAS  Google Scholar 

  19. Barentsen R, van de Weijer PH, Schram JH (1997) Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet Gynecol Reprod Biol 71:73–80

    Article  PubMed  CAS  Google Scholar 

  20. Dugal R, Hesla K, Sordal T, Aase KH, Lilleeidet O, Wickstrom E (2000) Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy. Acta Obstet Gynecol Scand 79:293–297

    Article  PubMed  CAS  Google Scholar 

  21. Kanne B, Jenny J (1991) Local administration of low-dose estriol and vital Lactobacillus acidophilus in postmenopause. Gynakol Rundsch 31:7–13

    Article  PubMed  CAS  Google Scholar 

  22. Raz R, Stamm WE (1993) A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 329:753–756

    Article  PubMed  CAS  Google Scholar 

  23. Dmochowski RR, Miklos JR, Norton PA, Zinner NR, Yalcin I, Bump RC (2004) Duloxetine urinary incontinence study group. Duloxetine versus placebo for the treatment of Noth American women with stress urinary incontinence. J Urol 170:1259–1263

    Article  Google Scholar 

  24. Berghmans LCM, Hendrikis HJM, Bo K, Hay-Smith EJ, de Bies RA, van Waalwijk, van Doorn ESC (1998) Conservative treatment if stress urinary incontinence in women: a systematic review of randomized clinical trials. Br J Urol 82:181–189

    Article  PubMed  CAS  Google Scholar 

  25. Castro RA, Arruda RM, Zanetti MRD, Santos PD, Sartori MGF, Girao MJBC (2008) Single-blind, randomized, controlled trial of pelvic floor muscle training, electrical stimulation, vaginal cones, and no active treatment in the management of stress urinary incontinence. Clinics 63:465–472

    Article  PubMed  Google Scholar 

  26. Leriche B, Conquy S (2010) Guidelines for rehabilitation management of non-neurological urinary incontinence in women. Prog Urol 20:S104–S108

    Article  PubMed  Google Scholar 

  27. Archer DF (2010) Efficacy and tolerability of local estrogen therapy for urogenital atrophy. Menopause 17:194–203

    Article  PubMed  Google Scholar 

  28. Shumaker SA, Woman JF, Uebersax JS, McClish D, Fantl JA (1994) Health-related quality-of-life measures for women with urinary incontinence—the incontinence impact questionnaire and the urogenital distress inventory. Qual Life Res 3:291–306

    Article  PubMed  CAS  Google Scholar 

  29. Mishell DR (1987) Menopause: physiology and pharmacology. Yearbook Medical Publisher, Chicago

    Google Scholar 

  30. Wied GL, Bibbo M (1975) Evaluation of endocrinologic condition by exfoliative cytology. In: Gold JJ (ed) Textbook of gynaecologic endocrinology. Harper and Row, New York, pp 117–155

    Google Scholar 

  31. Ishiko O, Hirai K, Sumi T, Tatsuta I, Ogita S (2001) Hormone replacement therapy plus pelvic floor muscle exercise for postmenopausal stress incontinence. A randomized, controlled trial. J Reprod Med 46:213–220

    PubMed  CAS  Google Scholar 

  32. Schar G, Kochli OR, Fritz M, Heller U (1995) Effect of vaginal estrogen therapy on urinary incontinence in postmenopause. Zentralbl Gynakol 117:77–80

    PubMed  CAS  Google Scholar 

  33. Lose G, Englev E (2000) Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. BJOG 107:1029–1034

    Article  PubMed  CAS  Google Scholar 

  34. Bhatia NN, Bergman A, Karram MM (1989) Effects of estrogen on urethral function in women with urinary incontinence. Am J Obstet Gynecol 160:176–181

    PubMed  CAS  Google Scholar 

  35. Hilton P, Stanton SL (1983) The use of intravaginal estrogen cream in genuine stress incontinence. Br J Obstet Gynaecol 90:940–944

    Article  PubMed  CAS  Google Scholar 

  36. Sturdee DW, Panay N, International Menopause Society Writing Group (2010) Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 13:509–522

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

  1. Urogynecology Unit, Gynecologic and Obstetric Clinic, University of Sassari, Viale San Pietro 12, 07100, Sassari, Italy

    Giampiero Capobianco, Ermes Donolo, Gianna Borghero, Francesco Dessole, Pier Luigi Cherchi & Salvatore Dessole

Authors
  1. Giampiero Capobianco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ermes Donolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gianna Borghero
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Francesco Dessole
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pier Luigi Cherchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Salvatore Dessole
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giampiero Capobianco.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Capobianco, G., Donolo, E., Borghero, G. et al. Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women. Arch Gynecol Obstet 285, 397–403 (2012). https://doi.org/10.1007/s00404-011-1955-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-011-1955-1

Keywords

Search

Navigation